Akums Drugs & Pharmaceuticals Ltd
Healthcare
Can Quadria Capital meet benchmark in partial exit from India healthcare bet?
Singapore- and Delhi-based private equity firm Quadria Capital, which aims to raise up to $1 billion for its latest fund......
Healthcare
Quadria Capital waives buyback right to exit Indian drugmaker
Singapore- and Delhi-based private equity firm Quadria Capital, which is on the road to raise up to $1 billion for ......
Healthcare
Quadria Capital hits sell button on its second-largest India healthcare bet
Singapore and Delhi-based private equity firm Quadria Capital, which marked the first close of its third investment ......
Finance
Quadria Capital hits final close of second healthcare fund, overshoots target
Singapore-based private equity firm Quadria Capital has closed its second fund at its maximum fund size of $595 million, it ......
Healthcare
Quadria Capital seals debut deal from new PE fund in Delhi-based drugmaker
Singapore- and Delhi-based private equity firm Quadria Capital is close to striking its debut bet from its new healthcare-focused...
Healthcare
Parabolic Drugs set to chart recovery path as lenders approve takeover bid
Debt-laden Parabolic Drugs Ltd is headed on the road to recovery after its lenders gave their stamp of approval to ......
Healthcare
Sequoia eyes quick exit from Akumentis in control deal
Venture capital and growth-stage investor Sequoia Capital is looking to exit Akumentis Healthcare Ltd in a transaction where the drugmaker’s ......
Healthcare
Drugmaker Akums hires banker for potential majority stake sale
Contract drug manufacturer Akums Drugs & Pharmaceuticals Ltd has hired a banker for a stake sale, three people familiar with ......





